As of August 2, 2025, Pro Medicus Ltd (PME.AX) reports a ROE (Return on Equity) of 44.10%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Pro Medicus Ltd's ROE (Return on Equity)
Over recent years, Pro Medicus Ltd's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-06-30 | 44.10% |
| 2023-06-30 | 43.70% |
| 2022-06-30 | 43.69% |
| 2021-06-30 | 37.77% |
| 2020-06-30 | 38.34% |
This steady improvement highlights how Pro Medicus Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Pro Medicus Ltd's ROE (Return on Equity) to Peers
To better understand Pro Medicus Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Pro Medicus Ltd (PME.AX) | 44.10% |
| Intellicentrics Global Holdings Ltd (6819.HK) | 222.63% |
| 1st Group Ltd (1ST.AX) | 54.24% |
| Global Health Ltd (GLH.AX) | 45.25% |
| Infinitt Healthcare Co Ltd (071200.KQ) | 24.69% |
| Findex Inc (3649.T) | 20.75% |
Compared to its competitors, Pro Medicus Ltd's ROE (Return on Equity) is among the highest compared to peers, suggesting efficient use of shareholder equity to generate profits.